Earnings Feed
Start Free
Home/Filings/4/0001127602-22-011636
4//SEC Filing

Lotvin Alan 4

Accession 0001127602-22-011636

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 7:28 PM ET

Size

18.1 KB

Accession

0001127602-22-011636

Insider Transaction Report

Form 4
Period: 2022-04-01
CVS HEALTH CorpCVS
Lotvin Alan
EVP, Transformation
Transactions
  • Tax Payment

    Common Stock

    2022-04-01$101.09/sh−38,129$3,854,461→ 109,183.369 total
  • Award

    Stock Option

    2022-04-01$101.09/sh+77,962$7,881,179→ 77,962 total
    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (77,962 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    492

  • Stock Unit

    30,005.656

  • Phantom Stock Credits

    Exercise: $1.00→ Common Stock (554.276 underlying)
    554.276

  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (27,395 underlying)
    27,395

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (32,911 underlying)
    32,911

  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (22,541 underlying)
    22,541

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (70,702 underlying)
    70,702

  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (140,797 underlying)
    140,797

  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (120,940 underlying)
    120,940
Footnotes (11)
  • [F1]Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022.
  • [F10]Option became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F11]Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
  • [F2]Option becomes exercisable in four equal installments, commencing 4/1/2023.
  • [F3]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F4]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2017.
  • [F6]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F7]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F8]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F9]The number of shares subject to the option were calculated using a 30-day average price.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001472795

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 7:28 PM ET
Size
18.1 KB
View on SEC.gov